Table 1.
ID | Age | Sex | Year of diagnosis | Medications | UPDRS III DBS OFF | UPDRS III DBS ON |
---|---|---|---|---|---|---|
STN1 | 58 | M | 2004 | Sinemet, amantadine | 64 | 36 |
STN2 | 73 | M | 2001 | Madopar, rotigotine, entacapone, rasagiline | 26 | 10 |
STN3 | 63 | M | 1994 | Ropinirole, amitriptyline | 55 | 37 |
STN4 | 64 | M | 1996 | Sinemet, ropinirole, tolcapone, rasagiline | 51 | 16 |
STN5 | 59 | M | 1996 | Madopar, Stalevo | 39 | 27 |
STN6 | 47 | M | 2009 | Madopar, rotigotine, rasagiline | 45 | 27 |
GPi1 | 58 | M | 2003 | Sinemet, pramipexole | 41 | 33 |
GPi2 | 72 | F | 2002 | Sinemet, pramipexole | 25 | 16 |
GPi3 | 77 | M | 2001 | Stalevo, selegiline | 35 | 30 |
GPi4 | 64 | M | 2003 | Madopar | 31 | 22 |
GPi5 | 58 | M | 1998 | Sinemet, Stalevo, rotigotine, amantadine | 19 | 11 |
GPi6 | 67 | M | 2006 | Sinemet, Stalevo | 35 | 19 |
GPi7 | 62 | M | 2007 | Sinemet | 40 | 21 |
GPi8 | 54 | M | 2005 | Madopar, amantadine, entacapone, rasagiline | 30 | 25 |
Unified Parkinson's Disease Rating Scale (UPDRS) part III scores are with DBS on and off (patients were on their medication in both cases). Sinemet contains levodopa and carbidopa; Stalevo contains levodopa, carbidopa, and entacapone; and Madopar contains levodopa and benserazide. M, Male; F, female.